JetBlue Airways
This stock has been obliterated over the past two months even though the carrier holds a commanding position on the east coast of the United States. JetBlue Airways Corp. (NASDAQ: JBLU) provides air transportation services. As of December 31, 2021, the company operated a fleet of 63 Airbus A321 aircraft, eight Airbus A220 aircraft, 21 Airbus A321neo aircraft, 130 Airbus A320 aircraft and 60 Embraer E190 aircraft.
The carrier serves 107 destinations in 31 states, the District of Columbia, Puerto Rico, the U.S. Virgin Islands, and 24 countries in the Caribbean and Latin America. The company also has a strategic partnership with American Airlines to create connectivity for travelers in the Northeast.
The Deutsche Bank target price is $8.50, and JetBlue Airways stock has a consensus target of $8.31. On Friday, shares traded at $6.90.
Peloton Interactive
This cycling and exercise platform was a huge pandemic winner but has been hammered this past year. Peloton Interactive Inc. (NASDAQ: PTON) operates interactive fitness platforms in North America and internationally. The company offers connected fitness products with touchscreens that stream live and on-demand classes under the Peloton Bike, Peloton Bike+, Peloton Tread and Peloton Tread+ names.
The company also provides connected fitness subscriptions for various household users and access to various live and on-demand classes. Its Peloton Digital app for connected fitness subscribers provides access to its classes. As of June 30, 2022, it had approximately 6.9 million members. The company markets and sells its interactive fitness products directly through its retail showrooms and online.
The company announced last November a partnership with Dick’s Sporting Goods to sell their exercise bikes through the retail giant. Peloton’s exercise hardware (minus its new rowing machine) is available for sale at 100 Dick’s Sporting Goods locations.
Bank of America Securities has set a $13 target price, and the consensus target is $12.41. Peloton Interactive stock traded on Friday at $7.00.
Teva Pharmaceutical
This leading generic drug maker is trading at 25-year lows and could be a steal at current prices. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) develops, manufactures, markets and distributes generic medicines, specialty medicines and biopharmaceutical products in North America, Europe and elsewhere.
The company offers sterile products, hormones, high-potency drugs and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments and creams. It also manufactures and sells active pharmaceutical ingredients, as well as provides contract manufacturing services, and it operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. In addition, it focuses on the central nervous system (CNS), pain, respiratory and oncology areas.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.
